1. Home
  2. PRAX vs CUBE Comparison

PRAX vs CUBE Comparison

Compare PRAX & CUBE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Praxis Precision Medicines Inc.

PRAX

Praxis Precision Medicines Inc.

HOLD

Current Price

$331.79

Market Cap

9.6B

Sector

Health Care

ML Signal

HOLD

Logo CubeSmart

CUBE

CubeSmart

HOLD

Current Price

$38.53

Market Cap

8.8B

Sector

Real Estate

ML Signal

HOLD

Company Overview

Basic Information
Metric
PRAX
CUBE
Founded
2015
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Real Estate Investment Trusts
Sector
Health Care
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
9.6B
8.8B
IPO Year
2020
2004

Fundamental Metrics

Financial Performance
Metric
PRAX
CUBE
Price
$331.79
$38.53
Analyst Decision
Strong Buy
Buy
Analyst Count
15
15
Target Price
$572.13
$44.08
AVG Volume (30 Days)
345.8K
2.3M
Earning Date
05-01-2026
04-30-2026
Dividend Yield
N/A
5.45%
EPS Growth
N/A
N/A
EPS
N/A
1.46
Revenue
N/A
$1,123,110,000.00
Revenue This Year
N/A
$0.66
Revenue Next Year
$6,395.88
$2.82
P/E Ratio
N/A
$26.62
Revenue Growth
N/A
5.33
52 Week Low
$28.79
$35.09
52 Week High
$354.87
$44.13

Technical Indicators

Market Signals
Indicator
PRAX
CUBE
Relative Strength Index (RSI) 57.17 55.98
Support Level $282.49 $38.41
Resistance Level $327.65 $39.46
Average True Range (ATR) 17.60 0.74
MACD 2.86 0.31
Stochastic Oscillator 81.68 82.03

Price Performance

Historical Comparison
PRAX
CUBE

About PRAX Praxis Precision Medicines Inc.

Praxis Precision Medicines Inc is a clinical-stage biopharmaceutical company. It is engaged in translating genetic insights into the development of therapies for patients affected by central nervous system disorders characterized by a neuronal excitation-inhibition imbalance. The company applies genetic insights to the discovery and development of therapies for neurological disorders through two proprietary platforms: Cerebrum and Solidus. It has established a diversified, multimodal CNS portfolio with four clinical-stage product candidates across movement disorders and epilepsy, which include Ulixacaltamide, Relutrigine, Vormatrigine, and Elsunersen. The firm operates in only one segment and is focused on discovering and developing therapies for CNS disorders.

About CUBE CubeSmart

CubeSmart is a real estate investment trust that acquires, owns, and manages self-storage facilities throughout the United States. The company's real estate portfolio is composed of buildings with numerous enclosed storage areas for both residential and commercial customers to rent mainly on a month-by-month basis. Majority of CubeSmart's facilities are located in Florida, Texas, California, New York, and Illinois. Cumulatively, these states account for both the majority of the square footage in the company's real estate portfolio and the majority of its revenue. The company derives nearly all of its revenue from rental income from tenants utilizing its storage facilities.

Share on Social Networks: